PRME
Prime Medicine, Inc. Common Stock
NASDAQ: PRME · HEALTHCARE · BIOTECHNOLOGY
$3.53
-4.34% today
Updated 2026-04-29
Market cap
$666.47M
P/E ratio
—
P/S ratio
143.88x
EPS (TTM)
$-1.35
Dividend yield
—
52W range
$1 – $7
Volume
2.5M
WallStSmart proprietary scores
19
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.5
Profitability
F4.7
Valuation
C—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$6.92
+96.03%
12-Month target
—
—
Intrinsic (DCF)
$3.01
Margin of safety
-14.62%
1 Strong Buy8 Buy4 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-37.55M
- Revenue declining -61.60% QoQ
- 14.62% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $5.21M | $0.00 | $2.98M | $4.63M | $4.63M |
| Net income | $-121.82M | $-198.13M | $-195.88M | $-201.14M | $-46.08M |
| EPS | — | — | — | — | $-1.35 |
| Free cash flow | $-147.92M | $-174.14M | $-130.16M | $-167.09M | $-37.55M |
| Profit margin | -2,338.21% | — | -6,566.61% | -4,342.44% | — |
Peer comparison
Smart narrative
Prime Medicine, Inc. Common Stock trades at $3.53. Our Smart Value Score of 19/100 indicates the stock is weak. TTM revenue stands at $4.63M. Our DCF model estimates intrinsic value at $3.01.
Frequently asked questions
What is Prime Medicine, Inc. Common Stock's stock price?
Prime Medicine, Inc. Common Stock (PRME) trades at $3.53.
Is Prime Medicine, Inc. Common Stock overvalued?
Smart Value Score 19/100 (Grade F, Strong Sell). DCF value $3.01.
What is the price target of Prime Medicine, Inc. Common Stock (PRME)?
The analyst target price is $6.92, representing +96.0% upside from the current price of $3.53.
What is the intrinsic value of Prime Medicine, Inc. Common Stock (PRME)?
Based on our DCF model, intrinsic value is $3.01, a -14.6% margin of safety versus $3.53.
What is Prime Medicine, Inc. Common Stock's revenue?
TTM revenue is $4.63M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio143.88x
ROE-146.80%
Beta2.67
50D MA$3.71
200D MA$4.08
Shares out0.18B
Float0.11B
Short ratio—
Avg volume2.5M
Performance
1 week-3.91%
1 month+6.03%
3 months-11.08%
YTD+6.34%
1 year—
3 years—
5 years—